LyondellBasell 2025-26: $1.3B Cash Plan, FY26 Capex $1.2B, Cycle Low
FY25 revenue $30.15B (-25%); op income -$327M (vs +$1.82B FY24); NI -$743M (vs +$1.36B); EPS -$2.35 (vs $4.15). Industry margins ~45% below historical averages — cycle low. Value enhancement program: $1.1B recurring annual EBITDA achieved 2025; $1.5B target by 2028. Cash improvement $800M FY25 (vs $600M target); cumulative $1.3B target through 2026 (incremental $500M FY26). FY26 capex ~$1.2B; effective tax ~10%.
Key takeaways
- Industry margins ~45% below historical averages — cycle trough. Mgmt explicit: this is one of the deepest cycle troughs in petrochemical history. Revenue -25% YoY reflects volume + price compression. Op income flipped negative (-$327M) and NI -$743M. EPS -$2.35 (vs $4.15) — meaningful loss year.
- Value enhancement program $1.1B recurring EBITDA achieved 2025; $1.5B by 2028. This is the structural margin lever — cost reduction + commercial execution + portfolio optimization. The $1.1B is "in the run rate" — durable savings already realized.
- Cash improvement program: $800M FY25 (vs $600M target). Beat the original target by $200M. FY26 incremental $500M planned; cumulative $1.3B through 2026. Working capital + capex + non-core asset sales.
- FY26 capex $1.2B (vs higher prior cycles). $400M for profitable growth; $800M for sustaining. Capex moderation reflects cycle discipline + completion of growth projects + cash conservation.
- 2025 was LyondellBasell's safest year on record. Total recordable incident rate at record low despite elevated maintenance activity. Operational excellence even during cycle trough.
Business
LyondellBasell Industries is a global petrochemical + refining + polymer + technology licensor. Five reportable segments:
- Olefins and Polyolefins Americas (O&P Americas) (~30% of revenue). Ethylene + polyethylene + polypropylene cracking + production primarily in US Gulf Coast. Q4 EBITDA $164M (down on higher feedstock + lower polyethylene margins + maintenance). Q4 operating rate ~75%; FY26 Q1 expected ~85%.
- Olefins and Polyolefins Europe, Asia, International (O&P EAI) (~25%). European + Asian olefins + polyolefins. Q4 EBITDA -$61M (loss) — seasonal lower prices + maintenance + weak demand + low-cost imports competition. The structurally challenged segment.
- Intermediates and Derivatives (I&D) (~25%). Oxyfuels + propylene oxide + propylene glycol + acetyls + isocyanates. Q4 EBITDA $205M. Oxyfuels margins softening; PG demand improving; acetyls turnaround drag.
- Advanced Polymer Solutions (APS) (~15%). Specialty polymers + compounding. Q4 EBITDA $38M; +55% YoY despite seasonal volume softness — commercial execution + cost discipline.
- Refining + Technology (~5%). Houston refinery + technology licensing. Q4 Technology EBITDA $80M; FY26 Q1 lower on seasonal licensing decline.
Strategic moves FY25:
- Value enhancement program: $1.1B recurring EBITDA achieved (2025 milestone)
- Cash improvement program: $800M (vs $600M target FY25)
- $1.3B cumulative cash improvement target through 2026 (incremental $500M FY26)
- Three strategic pillars: grow + upgrade core / build profitable circle + low carbon / step up performance + culture
- 2025 safest year on record (record low TRIR)
- Capex $1.88B FY25 (full deployment + maintenance turnarounds)
- $201M buyback FY25 (modest given cycle); $1.76B dividend (+2.5% YoY)
- Refinery + cracker maintenance through year
FY25 financial performance
| Metric (FY) | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue ($B) | 50.45 | 41.11 | 40.30 | 30.15 |
| Revenue YoY | n/a | -19% | -2% | -25% |
| Op income ($B) | 5.10 | 3.05 | 1.82 | -0.33 |
| Op margin | 10.1% | 7.4% | 4.5% | -1.1% |
| Net income ($B) | 3.88 | 2.11 | 1.36 | -0.74 |
| Diluted EPS ($) | 11.80 | 6.46 | 4.15 | -2.35 |
| FCF ($M) | 4,229 | 3,411 | 1,980 | 384 |
| Capex ($B) | -1.89 | -1.53 | -1.84 | -1.88 |
| Total debt ($B) | 13.18 | 13.00 | 12.92 | 15.96 |
| Dividends ($B) | -3.25 | -1.61 | -1.72 | -1.76 |
| Buyback ($M) | -420 | -211 | -195 | -201 |
The earnings progression tells the cycle: FY22 was peak ($11.80 EPS / $5.1B op income); FY23 + FY24 saw progressive compression as cycle softened; FY25 is the trough year (-$2.35 EPS, -$0.74B NI). The FCF compression from $4.2B FY22 → $384M FY25 illustrates the cyclical cash flow deterioration.
Op margin -1.1% FY25 is the cleanest cyclical signal. Total debt $15.96B (+24% YoY) reflects the cycle — debt issuance to maintain dividend + capex + cash flow gap.
The Q4 segment-level data shows the cycle dynamics: O&P Americas operating at 75% (vs 90% peak); O&P EAI at -$61M loss (seasonal + import competition). FY26 Q1 expected to recover to ~85% operating rate, suggesting cycle bottom may be behind.
Capital allocation
- Capex $-1.88B FY25 (~6% of revenue). FY26 plan: $1.2B ($400M growth + $800M sustaining) — moderation from prior cycle.
- Dividends $-1.76B FY25 (+2.5% YoY). Mgmt explicit dividend has not been cut despite earnings trough — financed by debt.
- Buybacks $-201M FY25 (modest). The buyback discipline through cycle is intact but limited.
- Debt $15.96B (+24% YoY). Cycle-driven debt buildup.
- Cash improvement $800M FY25 (beat $600M target by $200M); $1.3B cumulative through 2026.
- FCF $384M FY25 — barely positive. The FY26 cash improvement target is critical to maintaining capital return capacity.
FY26 outlook (per Q4 2025 call, 2026-01-30)
| FY26 framework | Detail |
|---|---|
| Cash improvement | $500M incremental (cumulative $1.3B target through 2026) |
| Capex | ~$1.2B ($400M growth + $800M sustaining) |
| Effective tax rate | ~10% |
| Cash tax rate | ~10pp higher than effective |
| Q1 operating rates | O&P Americas ~85%; I&D ~85% |
| Value enhancement program target | $1.5B recurring annual EBITDA by 2028 |
Mgmt did not provide explicit revenue or EPS guidance — typical of cyclical petrochemical companies. The framework suggests cycle inflection in FY26 + continued structural margin programs.
Key risks
Industry margins ~45% below historical averages. This is the central risk — when do margins normalize? Historical petrochemical cycles take 18-36 months to recover from troughs. The FY25 trough has lasted 12+ months; recovery timing depends on demand growth + supply discipline.
Global trade disruptions + low durable goods demand. Q4 mgmt highlighted these as key headwinds. Polymers + petrochemicals demand correlates strongly to global economic activity, durable goods consumption, automotive sales, construction. Continued global slowdown extends the cycle trough.
Lower oil-to-gas ratio. Petrochemical economics depend on the relative cost of oil-based vs gas-based feedstocks. Currently low oil-to-gas ratio favors US Gulf Coast gas-based crackers (LYB advantage) but the spread can compress if oil prices weaken further.
Increased import competition in Europe. European O&P segment (-$61M Q4 EBITDA) is exposed to imports from Middle East + Asia where energy costs are structurally lower. European petrochemical industry consolidation underway — LYB's European footprint at risk of further losses.
Structurally higher European energy costs. Post-2022 energy crisis, European natural gas + electricity costs remain elevated. This is a multi-year structural disadvantage for European chemicals.
Geopolitical uncertainty + oxyfuels markets. Q4 mgmt flagged oxyfuels markets as volatile due to geopolitical (Middle East / Russia / sanctions). I&D segment includes oxyfuels exposure.
Refining cycle. Houston refinery economics correlate to crack spreads + refinery utilization. Refining is inherently volatile.
Dividend sustainability at trough. $1.76B annual dividend at $384M FCF = unsustainable absent recovery or debt issuance. Mgmt has signaled dividend continuity but the math constrains capital return capacity if cycle persists.
Cash improvement program execution. $1.3B cumulative target depends on working capital optimization + non-core sales + capex discipline. Execution is critical to maintaining capital flexibility.
Bottom line
LyondellBasell FY25 is the petrochemical cycle trough year: revenue -25%, op margin -1.1%, NI -$743M, EPS -$2.35, FCF compressed to $384M. Industry margins ~45% below historical averages — the cycle is in deep trough.
The structural levers are intact: value enhancement program $1.1B recurring annual EBITDA achieved (target $1.5B by 2028), cash improvement program $800M FY25 (vs $600M target, beat by $200M), FY26 capex $1.2B (moderation), 2025 safest year on record. Q4 sequential trends suggest cycle stabilization with FY26 Q1 operating rates +10pp from Q4. The FY26 cash improvement target of $500M incremental ($1.3B cumulative through 2026) is critical to maintaining capital return capacity.
The risks are dominant: industry margins, global trade, durable goods demand, Europe import competition + structural energy costs, oxyfuels volatility, refining cycle, dividend sustainability, cash improvement execution. The cycle could extend further if demand recovery delays.
But the structural thesis (US Gulf Coast cracker scale + technology licensing + portfolio optimization + cash improvement program + dividend continuity) is intact. Cycle troughs are by definition the worst points in time — the underlying business and balance sheet support FY26-27 normalization. Quality petrochemical operator at deep cycle trough; investors with multi-year horizon and dividend tolerance can buy at this point with reasonable expectation of cycle recovery + value enhancement program payoff by 2027-2028.
Citations
- LyondellBasell Industries N.V. FY25 Form 10-K (filed February 2026, SEC EDGAR).
- LYB Q4 2025 earnings call, 2026-01-30 — industry margins ~45% below historical; value enhancement program $1.1B achieved 2025 / $1.5B target by 2028; cash improvement $800M FY25 (vs $600M target) + $500M incremental FY26 / cumulative $1.3B; FY26 capex ~$1.2B ($400M growth + $800M sustaining); effective tax ~10%; 2025 safest year on record; Q1 operating rates ~85%.
- LYB Q3 2025 / Q2 2025 / Q1 2025 earnings calls — supporting cycle dynamics + value enhancement progress + segment performance (assumed in line with Q4 trajectory).
- Internal financial_statements view (consolidated annual + cash flow + capital structure).